C-JCOGSignum Biosciences
lipid ligand mimetics, STMs, botanical extracts
modulatingsmall molecule
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-JCOG
C-JCOGC-JCOGlipid ligand mimetics, STMs, botanical extracts
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Signum Biosciences states that health can be preserved by targeting cellular regulation and signaling pathways, and that failures in human cell signaling underlie diseases such as Alzheimer's, Parkinson's, atherosclerosis, and skin conditions. The company says it applies molecular biochemistry to design and identify compounds that can prevent and treat these signaling-related diseases.
SourceSignum Biosciences states that it is focused on exploiting new technologies related to cellular regulation and signaling, and that it believes molecular biochemistry tools can be used to design and identify compounds that prevent and treat diseases caused by failures in human cell signaling systems, including Alzheimer's, Parkinson's, atherosclerosis, and skin conditions.
SourceNo company beliefs, mission, or scientific/longevity theories are stated in the visible text of this snapshot. The page is a default ValueWeb hosting placeholder for signumbiosciences.com and only contains setup and hosting instructions.
SourceSignum Biosciences states that diseases of aging, including Alzheimer's, can be addressed by applying molecular biochemistry to botanical targets, using patented assays of global methyl regulation to identify and characterize promising candidates. The company presents botanical compounds as a practical path to therapeutics and preventives because their history of human use may streamline development into pharmaceuticals, nutritional supplements, and botanical drugs.
Source